BSE · KIMIABL

KIMIA BIOSCIENCES LIMITED

Sector: Healthcare · ISIN: INE285U01025

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#2,640

of 5,088 stocks

🏆 New peak

▲ 591W

Peak #2,640 · 30 Sep 2026

A microcap name in Healthcare, KIMIA BIOSCIENCES LIMITED generates a high return on equity, remains firmly promoter-controlled, with promoters holding 75%, and is seeing revenue slip. Ownership as of Jun 2026.

Market Cap

151.40 Cr

P/E Ratio

19.51

P/B Ratio

0.85

ROE

41.95%

ROCE

28.50%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q4 2024-25
Revenue	20.72 Cr	27.20 Cr	30.10 Cr	38.24 Cr
Net Profit	35.58 L	37.31 L	5.44 Cr	1.99 Cr
EPS	0.08	0.15	1.15	0.42
Operating Profit	1.32 Cr	2.52 Cr	5.80 Cr	7.74 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

74.94%

Public

25.06%

PUBLIC BREAKDOWN

DII

0.38%

MF (within DII)

0.38%

Individuals

24.02%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
15 Nov 2018	Other	Reduction of Capital

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs